The genetic background of alopecia areata has only recently begun to get unraveled. We report the association of a case of pediatric alopecia areata with a rare genetic syndrome-blepharophimosis-ptosis-epicanthus inversus syndrome (BPES), which responded well to topical immunotherapy with diphenylcyclopropenone. In the background of increasing evidence surfacing on the genetic basis of alopecia areata, this association may be of significance.
Keywords: Alopecia areata; blepharophimosis-ptosis-epicanthus inversus syndrome; contact immunotherapy; diphenylcyclopropenone; genetic basis.